virtual care and digital medicine provider bio for miss raising
300 million. The series D round led by general
atlantic cBS health also participated in the round and offers
at home care and digital therapies backed by artificial intelligence
which can remotely monitor patients while they're at home.
The company says it hopes its technology can improve patient
outcomes while reducing the cost and the burden of care
. And joining me now is the founder and ceo
of by a form ist Kuldeep Singh rajput called it
. Thank you so much for coming on the show
to talk to me about a use case here for
this care solution First of all, thanks Christian for
having me. Um let's take an example, let's
take you know an example of a patient with heart
failure. Um and in the United States as we
know less than 1% of patients with heart failure are
an optimal dosage and less than 20% of these patients
even receive guideline directed medication therapy. Huge problem.
Um You know, one in four patients come back
and get re admitted into the hospital. So what
we really do um is we use sensors. Um
Educations where on on their body. We capture almost
five million data points on a daily basis. We
leverage artificial intelligence and derive a variety of novel biomarkers
Which enable us to predict heart failure worsening and clinical
complications ahead of time. But we then use our
Ai to personalize treatment. So we up titrate down
titrate switch medication so that patients are on the right
guideline directed therapy and we have demonstrated almost 57% reduction
in readmissions. We have demonstrated a 40% reduction in
poor oral cost of care. What would you say
to someone called deep who might be worried about their
precious healthcare data being misused here. Obviously you're using
a lot of sensors, You're using technology like artificial
intelligence to predict certain outcomes. Some people might be
on the fence about wanting to hand over that information
. What would you tell them? First of all
, you know, patients on their data, they
have complete control of what you know, they want
to do with it. Well, we of course
leverage all, you know, cutting edge technologies to
protect the data. We comply with all the local
regulations um and most importantly some of the leading health
systems in the country and leading farmer customers, you
know, trust us and um you know, who
are our customers today now in terms of your customers
, I want you to walk me through those that
are on board. I know CVS participated in this
round. So I would imagine that there is some
sort of sharing partnership here embedded in the deal with
cbs. Yeah, so you know, we are
really excited to have cbs on board as part of
this round. Uh certainly one of our growth strategies
which we are very focused on is moving to value
based care and partnering with a C. O.
S. Health plans pairs and cBS certainly has influenced
infrastructure, there are pharmacies. PBMs they also have
a pair Etna which would enable us to, you
know, get access to a large patient population and
this is the first starting point. We are going
to continue to work with CVS but also continue to
work with the rest of the players in the country
. Now, in terms of expansion, I'm sure
that probably the sensors, this technology wants to predict
more things down the road called deep, how inclusive
can it be? That's a great question, christian
and first of all our fundamental pieces really is,
you know, personalized care. Um so we don't
look at the population as a whole are models are
built on you as an individual, we compare you
to you and that enables us to be more predictive
that enables us to provide more personalized care. So
it's all about you as a person and we use
AI and our Ai is trained to focus on you
as a person and it continues to get better and
better and eventually we are able to drive better outcomes
. Alright, Kuldeep Singh rajput Ceo and founder bio
for missed with a new funding round, congratulations and
thank you